Publications for Kirsten Morley
Publications for Kirsten Morley
Drugs, Melbourne.
2014
Morley, K., Haber, P., Morgan, M., Samara, F.
(2012). Pericyazine in the treatment of cannabis
dependence in general practice: a naturalistic
pilot trial. Substance Abuse and Rehabilitation,
3, 43-47. <a
href="http://dx.doi.org/10.2147/SAR.S30052">[
More Information]</a>
Morley, K., Baillie, A., Leung, S., Addolorato,
G., Leggio, L., Haber, P. (2014). Baclofen for the
Treatment of Alcohol Dependence and Possible
Role of Comorbid Anxiety. Alcohol and
Alcoholism, 49(6), 654-660. <a
href="http://dx.doi.org/10.1093/alcalc/agu062">[
More Information]</a>
2010
Hunt, G., Siegfried, N., Morley, K., Sitharthan,
T., Cleary, M. (2014). Psychosocial interventions
for people with both severe mental illness and
substance misuse. Schizophrenia Bulletin, 40(1),
18-20. <a
href="http://dx.doi.org/10.1093/schbul/sbt160">[
More Information]</a>
Morley, K., Teesson, M., Sannibale, C., Baillie,
A., Haber, P. (2010). Clinical Predictors of
Outcome from an Australian Pharmacological
Relapse Prevention Trial. Alcohol and
Alcoholism, 45, 520-526. <a
href="http://dx.doi.org/10.1093/alcalc/agq068">[
More Information]</a>
Morley, K., Sitharthan, G., Haber, P., Tucker, P.,
Sitharthan, T. (2014). The Efficacy of an
Opportunistic Cognitive Behavioral Intervention
Package (OCB) on Substance Use and Comorbid
Suicide Risk: A Multisite Randomized
Controlled Trial. Journal of Consulting and
Clinical Psychology, 82(1), 130-140. <a
href="http://dx.doi.org/10.1037/a0035310">[Mo
re Information]</a>
Baillie, A., Stapinski, L., Crome, E., Morley, K.,
Sannibale, C., Haber, P., Teesson, M. (2010).
Some new directions for research on
psychological interventions for comorbid anxiety
and substance use disorders. Drug and Alcohol
Review, 29(5), 518-524. <a
href="http://dx.doi.org/10.1111/j.1465-3362.201
0.00206.x">[More Information]</a>
2013
Colagiuri, B., Morley, K., Boakes, R., Haber, P.
(2009). Expectancy in double-blind
placebo-controlled trials: an example from
alcohol dependence. Psychotherapy and
Psychosomatics, 78(3), 167-171. <a
href="http://dx.doi.org/10.1159/000206871">[M
ore Information]</a>
Morley, K., Baillie, A., Sannibale, C., Teesson,
M., Haber, P. (2013). Integrated care for
comorbid alcohol dependence and anxiety and/or
depressive disorder: study protocol for an
assessor-blind, randomized controlled trial.
Addiction Science & Clinical Practice, 8, 1-8. <a
href="http://dx.doi.org/10.1186/1940-0640-8-19"
>[More Information]</a>
Hunt, G., Siegfried, N., Morley, K., Sitharthan,
T., Cleary, M. (2013). Psychosocial interventions
for people with both severe mental illness and
substance misuse. Cochrane Database of
Systematic Reviews, 2013 (10), 1-258. <a
href="http://dx.doi.org/10.1002/14651858.CD00
1088.pub3">[More Information]</a>
Morley, K., Leung, S., Baillie, A., Haber, P.
(2013). The efficacy and biobehavioural basis of
baclofen in the treatment of alcoholic liver
disease (BacALD): Study protocol for a
randomised controlled trial. Contemporary
Clinical Trials, 36(2), 348-355. <a
href="http://dx.doi.org/10.1016/j.cct.2013.08.002
">[More Information]</a>
2012
Morley, K., Haber, P., Sitharthan, G., Tucker, P.,
Sitharthan, T. (2012). Clinical Predictors of
Suicidal Behaviour Among Patients with
Alcohol and/or Substance Abuse and Suicide
Risk. APSAD Conference, Australasian
Professional Society on Alcohol and other
2009
Haber, P., Lintzeris, N., Morley, K. (2009).
Pharmacotherapies for alcohol dependence. In
Paul Haber, Elizabeth Proude, Nick Lintzeris &
Olga Lopatko (Eds.), Guidelines for the
Treatment of Alcohol Problems, (pp. 93-106).
Australia: Commonwealth of Australia.
Morley, K., Teesson, M., Sannibale, C., Haber,
P. (2009). Sample bias from different recruitment
strategies in a randomised
controlled trial for alcohol dependence. Drug
and Alcohol Review, 28(3), 222-229. <a
href="http://dx.doi.org/10.1111/j.1465-3362.200
8.00022.x">[More Information]</a>
2008
Richardson, K., Baillie, A., Reid, S., Morley, K.,
Teesson, M., Sannibale, C., Weltman, M., Haber,
P. (2008). Do acamprosate or naltrexone have an
effect on daily drinking by reducing craving for
alcohol? Addiction, 103(6), 953-959. <a
href="http://dx.doi.org/10.1111/j.1360-0443.200
8.02215.x">[More Information]</a>
Thomson, C., Morley, K., Teesson, M.,
Sannibale, C., Haber, P. (2008). Issues with
Publications for Kirsten Morley
recruitment to randomised controlled trials in the
drug and alcohol field: a literature review and
Australian case study. Drug and Alcohol Review,
27(2), 115-122. <a
href="http://dx.doi.org/10.1080/0959523070182
9561">[More Information]</a>
2006
Richardson, K., Reid, S., Morley, K., Teesson,
M., Sannibale, C., Weltman, M., Baillie, A.,
Haber, P. (2006). The effects of alcohol and
naltrexone on craving and alcohol consumption.
Alcoholism: Clinical and Experimental
Research, 30(s2), 169A-169A.
Teesson, M., Morley, K., Reid, S., Sannibale, C.,
Thomson, C., Richardson, K., Haber, P. (2006).
The influence of depression on pharmacotherapy
for alcohol dependence. Alcoholism: Clinical
and Experimental Research, 30(s2), 68A-68A.
2005
Morley, K., Arnold, J., McGregor, I. (2005).
Serotonin (1A) receptor involvement in acute
3,4-methylenedioxymethamphetamine (MDMA)
facilitation of social interaction in the rat.
Progress in Neuro-Psychopharmacology and
Biological Psychiatry, 29(5), 648-657. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15908091">[More Information]</a>
2004
Morley, K., Li, K., Hunt, G., Mallet, P.,
McGregor, I. (2004). Cannabinoids Prevent The
Acute Hyperthermia And Partially Protect
Against The 5-Ht Depleting Effects Of Mdma
('Ecstasy') In Rats. Neuropharmacology, 46(7),
954-965.
Morley, K., Cornish, J., Li, K., McGregor, I.
(2004). Preexposure To Mdma ("Ecstasy")
Delays Acquisition But Facilitates
Mdma-Induced Reinstatement Of Amphetamine
Self-Administration Behavior In Rats.
Pharmacology, Biochemistry and Behavior,
79(2), 331-342.
2003
Cornish, J., Shahnawaz, Z., Thompson, M.,
Wong, S., Morley, K., Hunt, G., McGregor, I.
(2003). Heat increases
3,4-methylenedioxymethamphetamine
self-administration and social effects in rats.
European Journal of Pharmacology, 482(1-3),
339-341. <a
href="http://dx.doi.org/10.1016/j.ejphar.2003.09.
060">[More Information]</a>
McGregor, I., Gurtman, C., Morley, K.,
Clemens, K., Li, K., Blokland, A., Cornish, J.,
Hunt, G. (2003). Increased anxiety and
"depressive" symptoms months after MDMA
("ecstasy") in rats:
drug-induced hyperthermia does not predict
long-term outcomes. Psychopharmacology,
168(4), 465-474. <a
href="http://dx.doi.org/10.1007/s00213-003-145
2-8">[More Information]</a>
Gallate, J., Morley, K., Ambermoon, P.,
McGregor, I. (2003). The consequences of beer
consumption in rats: acute anxiolytic and ataxic
effects and withdrawal-induced anxiety.
Psychopharmacology, 166(1), 51-60. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=12474111">[More Information]</a>
2002
Gurtman, C., Morley, K., Li, K., Hunt, G.,
McGregor, I. (2002). Increased anxiety in rats
after 3,4-methylenedioxymethamphetamine:
association with serotonin depletion. European
Journal of Pharmacology, 446(1-3), 89-96.
2001
Morley, K., Gallate, J., Hunt, G., McGregor, I.,
Mallet, P. (2001). Increased anxiety and
impaired memory in rats 3 months after
administration of
3,4-methylenedioxymethamphetamine
("Ecstasy"). European Journal of Pharmacology,
433(1), 91-99.